CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling

Overview of attention for article published in Journal of Clinical Investigation, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 4 patents

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 63 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Aryl imidazoles for treatment of cancer

Grant US-11149047-B2

United States of America

Compositions and methods for treating cancers

Grant US-11104957-B2

United States of America

Aryl imidazoles and their use as anti-cancer agents

Grant US-10080739-B2

United States of America

Compositions and methods for treating cancers

Grant US-9567643-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.